Lead-in Study of VGB-R04 Gene Therapy for Hemophilia B-- An Observational Survey Analysis Study
Clinical trial NCT05442528 · UNKNOWN
Trial details
- NCT number
- NCT05442528
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.